Kelly Banas, Ph.D., principal investigator at ChristianaCare’s Gene Editing Institute, will present her latest research discovery related to targeting the NRF2 gene in cancer cells at the first CRISPR Medicine Conference held in Copenhagen, Denmark, April 22 to 25. The Gene Editing Institute’s research has focused on the NRF2 gene and the strong immune response […]
The post Kelly Banas, Ph.D., To Present Her Latest Discovery at CRISPR Medicine’s First International Conference appeared first on ChristianaCare News.
RELATED STORIES:
Reins of Honor Fundraiser Brings Healing to Veterans and Active-Military Through Horses
04/19/2025Taking ACT-ion for Quality Improvement
04/17/2025Bayhealth Honors 35 Graduates of Inpatient Nurse Residency Program
04/16/2025Delaware reports steady progress in air quality despite wildfire setbacks
04/16/2025Share this Post